@ShahidNShah
Duke, Mayo Clinic, others launch innovative AI collaboration
The goal of the new partnership, he said, is to "decentralize the high concentration of technology [and] regulatory expertise" from some leading health systems across the U.S., and use it to develop guidelines to help other organizations make smarter decisions. Duke has been in touch with Mayo Clinic for about 18 months building this initiative, said Sendak. Working alongside Mayo Clinic, "we, in parallel, had been putting together the internal processes for how to develop, evaluate these types of algorithms, and to inform not just IT decision makers but also clinical leaders for appropriate use of AI software." "We had reached very similar conclusions and approaches for how to develop and integrate AI software in clinical practice," Sendak said of Duke and Mayo. He and the firm "have been leaders in the field for many years now, helping commercial entities get adoption and navigate the regulatory process" said Sendak. The group wants to learn about key best practices and challenges faced by care delivery organizations in deploying healthcare AI said Sendak – with an early focus on three areas: procurement, integration and lifecycle management "In each of these settings, [we're interested in] seeing how those teams are staffed, how they make decisions, who the stakeholders are – because we want to leverage existing capabilities and processes that exist within health systems."
Continue reading at healthcareitnews.com
Make faster decisions with community advice
- 5 stats that reveal inequity in telemedicine
- Pharma-focused digital health accelerator PharmStars completes its inaugural program
- Prior Authorizations: 3 Ways to Reduce Administrative Burden & Burnout
- Why a new culture of innovation needs to be at the heart of the 'digital' NHS
- 10 Top Cardiology Stories in 2021
Next Article
-
Pharma-focused digital health accelerator PharmStars completes its inaugural program
PharmStars, a digital health accelerator focused on forging relationships between digital health companies and the life science world, has announced the culmination of its first 10-week program …
Posted Dec 14, 2021 Biosimilar Pharmaceuticals